1. STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through promoting autophagy by PI3K/Akt/mTOR pathway
   Ding Li et al, 2024, Archives of Biochemistry and Biophysics CrossRef
2. The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
   Ricardo A. León-Letelier et al, 2023, Frontiers in Oncology CrossRef
3. N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma
   Guowei Wang et al, 2022, Frontiers in Genetics CrossRef
4. TDO2 deficiency attenuates the hepatic lipid deposition and liver fibrosis in mice with diet-induced non-alcoholic fatty liver disease
   Zhi Qin et al, 2023, Heliyon CrossRef
5. Lnc NBAT1 Inhibits the Proliferation and Migration of Liver Cancer Cells Through the miR-21/PDCD4/AP-1 Signaling Axis
   Hongyan Zai et al, 2024, Applied Biochemistry and Biotechnology CrossRef
6. Identifying Proteins and Amino Acids Associated with Liver Cancer Risk: A Study Utilizing Mendelian Randomization and Bulk RNA Sequencing Analysis
   Chi Ma et al, 2024, Journal of Personalized Medicine CrossRef
7. Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
   Jing Cui et al, 2022, Disease Markers CrossRef
8. Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
   Xavier Thuru et al, 2022, Cancers CrossRef
9. Delivery of Adriamycin Loaded Niosomes for Liver Cancer Treatment
   Hanzhang Zhu et al, 2022, Journal of Biomedical Nanotechnology CrossRef
10. Radiation-Induced Bystander Effect on the Genome of Bone Marrow Mesenchymal Stem Cells in Lung Cancer
    Yi-Ming Zhang et al, 2023, Antioxidants & Redox Signaling CrossRef